Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices

被引:5
作者
Huang, Ming-Chao [1 ,2 ,3 ]
Hsieh, Ching-Hung [4 ,5 ]
Chang, Wei-Chun [6 ]
Chang, Shao-Tung [7 ]
Lee, Maw-Sheng [1 ,4 ,8 ]
机构
[1] Chung Shan Med Univ, Inst Med, 110,Sec 1,Jianguo N Rd, Taichung 40201, Taiwan
[2] Hsinchu MacKay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan
[3] Mackay Med Coll, New Taipei, Taiwan
[4] Lee Womens Hosp, Dept Obstet & Gynecol, Taichung, Taiwan
[5] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan
[6] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan
[7] Natl Taiwan Normal Univ, Dept Math, Taipei, Taiwan
[8] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan
来源
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY | 2018年 / 57卷 / 05期
关键词
Bladder training; Hydrodistention; Interstitial cystitis; O'Leary-Sant Interstistial Cystitis Symptom and Problem Indices; Painful bladder syndrome;
D O I
10.1016/j.tjog.2018.08.019
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To investigate whether the O'Leary-Sant Interstitial Cystitis Symptom Index (ICSI) and Interstitial Cystitis Problem Index (ICPI) is efficacy measure tool for interstitial Cystitis (IC) treatment with hydrodistention (HD) and bladder training (BT). Materials and methods: From January 2003 to March 2006, 108 consecutive IC patients were treated by HD and BT after HD. This study evaluated the efficacy of treatment with the specific questionnaire for IC, the ICSI and ICPI. Each patient filled out the questionnaire before HD and three months after HD and BT. The efficacy of the treatment was evaluated using the average scores of ICSI and ICPI. Results: The mean +/- margin of error, (95% confidence interval) of total scores of ICSI and ICPI were 13.89 +/- 2.95, (13.33-14.45) and 12.51 +/- 2.50, (12.04-12.98) before HD, respectively, and were 2.70 +/- 1.16, (2.44-2.95) and 1.99 +/- 1.27, (1.71-2.26) (all p < 0.005) three months after HD and BT, respectively. Conclusion: O'Leary-Sant ICSI and ICPI is not only a screening tool for IC but also a useful assessment tool for IC treatment outcomes. (C) 2018 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.
引用
收藏
页码:718 / 721
页数:4
相关论文
共 50 条
[41]   Clinical characteristics of self-reported nocturia in patients with interstitial cystitis, and effects of bladder hydrodistention (with fulguration of Hunner lesions) on nocturia [J].
Otsuka, Atsushi ;
Suzuki, Takahisa ;
Aki, Ryota ;
Matsushita, Yuto ;
Tamura, Keita ;
Motoyama, Daisuke ;
Ito, Toshiki ;
Sugiyama, Takayuki ;
Miyake, Hideaki .
LUTS-LOWER URINARY TRACT SYMPTOMS, 2019, 11 (02) :O141-O146
[42]   Bladder pain syndrome/interstitial cystitis: present and future treatment perspectives [J].
Diniz, S. ;
Dinis, P. ;
Cruz, F. ;
Pinto, R. .
MINERVA UROLOGICA E NEFROLOGICA, 2013, 65 (04) :263-276
[43]   Treatment Outcomes of Intravesical Botulinum Toxin A Injections on Patients with Interstitial Cystitis/Bladder Pain Syndrome [J].
Yu, Wan-Ru ;
Jiang, Yuan-Hong ;
Jhang, Jia-Fong ;
Chang, Wei-Chuan ;
Kuo, Hann-Chorng .
TOXINS, 2022, 14 (12)
[44]   PROLONGED BLADDER DISTENSION - EXPERIENCE IN THE TREATMENT OF DETRUSOR OVERACTIVITY AND INTERSTITIAL CYSTITIS [J].
MCCAHY, PJ ;
STYLES, RA .
EUROPEAN UROLOGY, 1995, 28 (04) :325-327
[45]   Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis/bladder pain syndrome [J].
Yu, Wan Ru ;
Peng, Tai Chu ;
Yeh, Hui Ling ;
Kuo, Hann-Chorng .
NEUROUROLOGY AND URODYNAMICS, 2019, 38 (06) :1602-1610
[46]   Current standard of care in treatment of bladder pain syndrome/interstitial cystitis [J].
Lopez, Sabela Rodriguez ;
Mangir, Naside .
THERAPEUTIC ADVANCES IN UROLOGY, 2021, 13
[47]   Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome [J].
Lee, Cheng-Ling ;
Kuo, Hann-Chorng .
TOXINS, 2015, 7 (10) :4283-4293
[48]   Qualitative analysis of treatment needs in interstitial cystitis/bladder pain syndrome: Implications for intervention [J].
McKernan, Lindsey C. ;
Bonnet, Kemberlee R. ;
Finn, Michael T. M. ;
Williams, David A. ;
Bruehl, Stephen ;
Reynolds, W. Stuart ;
Clauw, Daniel ;
Dmochowski, Roger R. ;
Schlundt, David G. ;
Crofford, Leslie J. .
CANADIAN JOURNAL OF PAIN-REVUE CANADIENNE DE LA DOULEUR, 2020, 4 (01) :181-198
[49]   Treatment effect of cyclosporine A in patients with painful bladder syndrome/interstitial cystitis: A systematic review [J].
Wang, Zhikui ;
Zhang, Lei .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (01) :445-450
[50]   Intravesical treatment for interstitial cystitis/painful bladder syndrome: a network meta-analysis [J].
Zhang, Wei ;
Deng, Xiaojing ;
Liu, Chunyu ;
Wang, Xu .
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2017, 28 (04) :515-525